JPRN-UMIN000007320已完成未知
The virology and clinical effects of peramivir on influenza virus infections in high-risk patients or patients with severe symptoms:an open-label, non-randomized, multi-centre study. - The virology and clinical effects of peramivir on influenza virus infections.
Center for Advanced Medical Innovation Kyushu University0 个研究点目标入组 20 人开始时间: 2012年2月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of hypersensitivity, allergy or serious adverse drug event caused by neuraminidase inhibitors. 2) Pregnant women. 3) Patients who are deemed to be inappropriate by the investigator.
研究者
相似试验
已完成
不适用
The clinical effects of peramivir on influenza virus infections in infants (age; over 28 days old, under 4 years old): an open-label,non-randomized, multi-centre study.Infants with Influenza virus infections.JPRN-UMIN000007328Takasaki Pediatric Clinic48
已完成
不适用
Comparison of clinical efficacy between peramivir and oseltamivir for the treatment of influenza in high-risk patientsInfluenza virus infectionJPRN-UMIN000010595Hamamatsu University School of Medicine60
已完成
不适用
Pharmacokinetics(PK) study of Peramivir in Epithelial Lining Fluid (ELF), an open-label study.healthy volunteerJPRN-UMIN000007758Keio University School of Medicine6
已完成
不适用
Efficacy and safety of simeprevir/pegylated-interferon/ribavirin combination therapy with Vitamin D3 in chronic hepatitis C patients: multi-center, open label, randomized, controlled studyChronic hepatitis CJPRN-UMIN000013017ippon Medical School Chiba Hokusoh Hospital150
进行中（未招募）
不适用
Antiviral effect, safety and pharmacokinetics of once daily BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naive patients for 24 weeks as combination therapy with pegylated interferon-a 2a and ribavirin (double-blinded, randomised, placebo-controlled, Phase II)EUCTR2008-003538-11-CZBoehringer Ingelheim RCV GmbH & Co. KG700